Sugi Predict

Sugi Predict / Compounds / SCHEMBL2228604

SCHEMBL2228604

SCHEMBL2228604

Cc1ccc(-c2cc(C3CCC(N4CCOCC4)CC3)nc3[nH]nc(N)c23)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 7/20 0.42
▸ STK4 Q13043 1/20 0.37
▸ STK3 Q13188 1/20 0.37
▸ PDPK1 O15530 2/20 0.37
▸ AURKA O14965 1/20 0.37
▸ IRAK4 Q9NWZ3 6/20 0.37
▸ KIT P10721 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ MAPK8 P45983 1/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ SYK P43405 1/20 0.35
▸ MAP3K12 Q12852 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230196 0.90 HRH3 (0.37) IGF1RPDPK1KITKDRFLT3
SCHEMBL2229472 0.89 HPGD (0.36) IGF1RKITKDRFLT3
SCHEMBL2230755 0.89 KDR (0.37) IGF1RSTK3PDPK1AURKAIRAK4
SCHEMBL2229238 0.86 BTK (0.48) STK3PDPK1IRAK4KITKDR
SCHEMBL2230493 0.81 BTK (0.41) PDPK1AURKAKITKDRFLT3
SCHEMBL2229913 0.81 HTT (0.41) IGF1RIRAK4
SCHEMBL2230446 0.79 TRPV3 (0.36) PDPK1AURKAKITKDRFLT3
SCHEMBL2232196 0.79 KDR (0.38) STK3AURKAIRAK4KITKDR
SCHEMBL2230090 0.77 BTK (0.53) STK3PDPK1IRAK4KITKDR
SCHEMBL6116000 0.77 BTK (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents MAP4K2, ABL1, MAP4K3 IGF1R 297/4885STK4 192/4885STK3 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.